Showing results (21-30 of 196) with videos related to
Sort By:
Pageof 20
Annals of Surgical Oncology|January 8, 2015
Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the LiteratureJaclyn Frances Hechtman, Ronald DeMatteo, Khedoudja Nafa, et al.Drug Discovery Today|September 1, 2015
Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trialsDavid M Hyman, David B Solit, Maria E Arcila, et al.Molecular Cancer Research : MCR|February 26, 2015
AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain MutantsJaclyn F Hechtman, Justyna Sadowska, Jason T Huse, et al.Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patientsSimon R Turner, Darren Buonocore, Patrice Desmeules, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Germline EGFR T790M mutation found in multiple members of a familial cohortHelena A Yu, Maria E Arcila, Megan Harlan Fleischut, et al.Lung Cancer (Amsterdam, Netherlands)|November 13, 2015
HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinibBob T Li, Adrian Lee, Sandra O'Toole, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutationsPaul K Paik, Maria E Arcila, Michael Fara, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 29, 2021
ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencingDonna C Ferguson, Amir Momeni Boroujeni, Tao Zheng, et al.The American Journal of Surgical Pathology|October 15, 2016
KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung AdenocarcinomaKyuichi Kadota, Camelia S Sima, Maria E Arcila, et al.Molecular Cancer Therapeutics|February 2, 2013
EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristicsMaria E Arcila, Khedoudja Nafa, Jamie E Chaft, et al.Pageof 20